Aridis Pharmaceuticals, Inc.
We are a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
$13.00 - $15.00
Cantor, Maxim Group LLC, Northland Capital Markets
To view the prospectus for Aridis Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277